The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
Get the basics on what healthcare supply chain and manufacturers, together with clinical and IT departments, must do to implement the Unique Device
Podcasts
A value analysis process to verify the achievement of the outcomes desired will result in making decisions based on the data, celebrating achieveme
On-Demand Educational Webinars
Cybersecurity impacts all industry verticals including health care. Health care organizations need to address security in standard technology and…
Podcasts
John Kelty from W.L.
On-Demand Educational Webinars
Today, health systems are being forced to leverage disparate data from internal and external sources to drive business intelligence solutions. In…
Resources
The AHRMM Keys for Supply Chain Excellence are Key Performance Indicators (KPIs) that set the standard for supply chain management in the health care…